| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2002 | WO2002002533A1 Propane-1,3-dione derivatives |
| 01/10/2002 | WO2002002531A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 01/10/2002 | WO2002002526A1 Pharmaceutical compositions for controlling intraocular pressure |
| 01/10/2002 | WO2002002525A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 01/10/2002 | WO2002002524A1 Pyrrole derivatives for treating aids |
| 01/10/2002 | WO2002002522A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002517A1 Acylsulfonamide derivatives |
| 01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002511A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 01/10/2002 | WO2002002509A1 Compounds and compositions for delivering active agents |
| 01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002498A1 Method for producing a non-fatty softener based on wax-esters |
| 01/10/2002 | WO2002002190A2 Prevention and treatment of neurodegenerative diseases by glutathione and phase ii detoxification enzymes |
| 01/10/2002 | WO2002002189A2 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 01/10/2002 | WO2002002182A2 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system |
| 01/10/2002 | WO2002002153A1 Inactivation of pathogens by porphyrins |
| 01/10/2002 | WO2002002147A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | WO2002002143A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 01/10/2002 | WO2002002140A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 01/10/2002 | WO2002002134A1 Use of secretin-receptor ligands in treatment of cystic fibrosis (cf) and chronic obstructive pulmonary disease (copd) |
| 01/10/2002 | WO2002002131A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | WO2002002130A1 Anti-viral composition |
| 01/10/2002 | WO2002002128A2 Oral compositions comprising antimicrobial agents |
| 01/10/2002 | WO2002002127A1 Extended type 1 chain glycosphingolipids as tumor-associated antigens |
| 01/10/2002 | WO2002002126A1 Medicaments containing dextrin for treating respiratory disorders such as cystic fibrosis |
| 01/10/2002 | WO2002002125A1 Injectable composition |
| 01/10/2002 | WO2002002124A1 Compositions containing ascorbic acid phosphoric acid esters |
| 01/10/2002 | WO2002002123A1 Use of geldanamycin and related compounds for prophylaxis or treatment of fibrogenic disorders |
| 01/10/2002 | WO2002002122A1 Ophthalmological drops with anti-imflammatory effect based on a wide-spectrum antibiotic and a local glucocorticoid |
| 01/10/2002 | WO2002002121A2 Method for treatment and prevention of mastitis |
| 01/10/2002 | WO2002002120A1 Novel use of inhibitors of the epidermal growth factor receptor |
| 01/10/2002 | WO2002002118A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 01/10/2002 | WO2002002116A2 Therapeutic treatment of cancer with a protein kinase c inhibitor |
| 01/10/2002 | WO2002002115A2 Anthelminthic agents for the prevention of parasitic infections in humans and animals |
| 01/10/2002 | WO2002002114A1 A new use for deferiprone |
| 01/10/2002 | WO2002002113A1 Pharmaceutical combination of an anti-androgen and letrozole for providing an anit-androgenic effect and aromatase inhibition |
| 01/10/2002 | WO2002002112A1 Pharmaceutical combination of an anti-androgen and anastrozole for providing an antiandrogenic effect and aromatase inhibition |
| 01/10/2002 | WO2002002111A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 01/10/2002 | WO2002002110A1 Use of indole-3-acetic acid derivatives in medicine |
| 01/10/2002 | WO2002002109A1 Use of galiella lactone |
| 01/10/2002 | WO2002002107A1 Pharmaceutical combination of bicalutamide and letrozole for providing an anti-androgenic effect and aromatase inhibition |
| 01/10/2002 | WO2002002106A1 Use of modified tall oil in combination with dietary supplements to improve body composition and health status |
| 01/10/2002 | WO2002002105A1 Therapeutic combinations of fatty acids |
| 01/10/2002 | WO2002002104A1 Urushiol induced contact dermatitis treatment and method of use |
| 01/10/2002 | WO2002002103A2 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 01/10/2002 | WO2002002102A1 Rapid fatty acid delivery |
| 01/10/2002 | WO2002002101A1 Hypoglycemics |
| 01/10/2002 | WO2002002100A1 Remedies for diabetes |
| 01/10/2002 | WO2002002099A1 Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition |
| 01/10/2002 | WO2002002098A2 Antibacterial method and composition with phenolic compounds |
| 01/10/2002 | WO2002002097A2 Methods for treating seizure disorders by inhibiting mapk pathway activation with nitriles |
| 01/10/2002 | WO2002002096A2 Oral compositions comprising host-response modulating agent |
| 01/10/2002 | WO2002002095A2 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
| 01/10/2002 | WO2002002094A2 Use of a protein kinase c inhibitor to enhance the clinical efficacy of anti-neoplastic chemotherapeutic agents and radiation therapy |
| 01/10/2002 | WO2002002093A2 Combination containing an antifolate and methylmalonic acid lowering agent |
| 01/10/2002 | WO2002002092A2 Compositions based on aminoacids, suitable for improving muscle performance |
| 01/10/2002 | WO2002002091A2 Methods and compositions for the treatment of alcoholism and alcohol dependence |
| 01/10/2002 | WO2002002090A2 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | WO2002002089A2 Anthelmintics for preventing parasitic infections in humans and animals |
| 01/10/2002 | WO2002002085A2 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 01/10/2002 | WO2002002084A1 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| 01/10/2002 | WO2002002079A1 Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
| 01/10/2002 | WO2002002078A2 Improved liposomal camptothecins and uses thereof |
| 01/10/2002 | WO2002002077A2 Liposomal antineoplastic drugs and uses thereof |
| 01/10/2002 | WO2002002076A2 Methods for treating inflammation-mediated conditions of the eye |
| 01/10/2002 | WO2002002075A1 Use of creatine and/or creatine derivatives in cosmetic or dermatological preparations |
| 01/10/2002 | WO2002002069A2 Cosmetic compositions containing substituted amine derivatives |
| 01/10/2002 | WO2002002067A1 Skin care cosmetic compositions containing carboxymethylates of branched alcohols and/or ethoxylates thereof |
| 01/10/2002 | WO2002002059A1 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 01/10/2002 | WO2002002056A2 Method of treatment of seborrheic dermatitis |
| 01/10/2002 | WO2002002011A1 Dna encoding human serine protease d-g |
| 01/10/2002 | WO2002001969A1 Vitamin k and essential fatty acids |
| 01/10/2002 | WO2002001956A1 Histidyl-proline diketopiperazine and method of use |
| 01/10/2002 | WO2002001954A1 Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury |
| 01/10/2002 | WO2001076758A8 Concentric tubular centrifuge |
| 01/10/2002 | WO2001070775A3 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 01/10/2002 | WO2001070709A3 3-oxy-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadazine-1,1-dioxide derivatives having diuretic and/or natriuretic activity |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001056993A3 Pyrazole compositions useful as inhibitors of erk |
| 01/10/2002 | WO2001055126A3 Synthesis of water soluble 9-dihydro-paclitaxel derivatives from 9-dihydro-13-acetylbaccatin iii |
| 01/10/2002 | WO2001052855A3 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 01/10/2002 | WO2001051042A3 Treatment of diabetic ulcers |
| 01/10/2002 | WO2001050881A3 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 01/10/2002 | WO2001049250A3 Treatment of acne using lipoic acid |
| 01/10/2002 | WO2001048483A3 Method for screening of appetite control agents |
| 01/10/2002 | WO2001047504A3 β-TUBELIN INHIBITORS AND THEIR USE AGAINST CANCER |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001045548A3 Surgical needle with weeping tip and method of use |
| 01/10/2002 | WO2001044455A3 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 01/10/2002 | WO2001043697A3 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 01/10/2002 | WO2001042444A3 Methods for expression of genes in primates |
| 01/10/2002 | WO2001042192A3 Vla-4 integrin antagonists |
| 01/10/2002 | WO2001039764A3 Methods for treating conditions and illnesses associated with abnormal vasculature |
| 01/10/2002 | WO2001039656A3 Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia |
| 01/10/2002 | WO2001038344A3 Modulation of signal transduction |
| 01/10/2002 | WO2001037785A3 Novel methods and compositions involving opioids and antagonists thereof |
| 01/10/2002 | WO2001036425A3 Imidazole compounds used as phosphodiesterase vii inhibitors |